HS-20197 for advanced solid tumors
Part of Cancer clinical trials.
This trial is testing an experimental drug called HS-20197 for people with advanced solid tumors (cancers that have spread or can't be removed). The goal is to see if it's safe and how well it works for a variety of solid tumor types.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have a solid tumor cancer that is advanced (has spread or cannot be surgically removed).
- You need to have at least one measurable tumor on imaging that is not in the brain.
- You must have recovered from serious side effects of past cancer treatments (only hair loss and certain nerve issues are allowed to remain).
- You must not have had certain cancer treatments (like chemo, radiation, or major surgery) within the last few weeks, and no live vaccines within 28 weeks.
- You must not have severe allergies or be allergic to the study drug's ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new drug called HS-20110 for people with advanced solid tumors that have not responded to other treatments. It aims to see if the drug is safe and can shrink tumors.
This early-phase trial tests a new drug (HS-20117) combined with other drugs for people with advanced solid tumors. It aims to see if the combination is safe and effective, especially for cancers that have not responded to other treatments.
This trial tests a new drug called HS-20122 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This trial tests an investigational medicine called HS-20117-2 for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it is safe and if it might help shrink or control the tumor.
This phase 1 study tests an investigational drug called HS-20108 in people with advanced solid tumors. It aims to find a safe dose and see how well the drug works against cancer.
This trial is testing a new drug called HS-20105, given by injection, for people with advanced solid tumors that have stopped responding to standard treatments. The drug targets a protein on cancer cells to try to slow or stop their growth.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.